Results 121 to 130 of about 129,296 (209)

Figure S4 from Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma

, 2023
Christopher M. Thompson, Andrew Cannon, Sean West, Dario Ghersi, Pranita Atri, Rakesh Bhatia, Lynette M. Smith, Satyayanarayana Rachagani, Christopher Wichman, Sushil Kumar, Surinder K. Batra   +10 more
openalex   +1 more source

KRAS Inhibition in Pancreatic Ductal Adenocarcinoma. [PDF]

J Clin Med
Pradeep R, Isbeih NJ, Abraham FF, Noori E, Yeung ZP, Kundranda MN.   +5 more
europepmc   +1 more source

Data from Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma

, 2023
Carla Mottini, Hideo Tomihara, Diego Carrella, Alessia Lamolinara, Manuela Iezzi, Justin K. Huang, Carla Azzurra Amoreo, Simonetta Buglioni, Isabella Manni, Frederick S. Robinson, Rosalba Minelli, Ya’an Kang, Jason B. Fleming, Michael P. Kim, Christopher A. Bristow, Daniela Trisciuoglio, Antonella Iuliano, Donatella Del Bufalo, Diego di Bernardo, Davide Melisi, Giulio Draetta, Gennaro Ciliberto, Alessandro Carugo, Luca Cardone   +23 more
openalex   +1 more source

Molecular Pathology of Pancreatic Ductal Adenocarcinoma. [PDF]

Cancers (Basel)
Shalaby A, Sadri N, Xue Y.
europepmc   +1 more source

BAG3‐positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma [PDF]

, 2019
Ye Yuan, Jingyi Jiang, Jia‐Mei Wang, Jia Sun, Chao Li, Bao‐Qin Liu, Jing Yan, Xiaona Meng, Hua‐Qin Wang   +8 more
openalex   +1 more source

Supplementary Table 7 from MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

, 2023
Nigel B. Jamieson, Douglas C. Morran, Jennifer P. Morton, Asif Ali, Euan J. Dickson, C. Ross Carter, Owen J. Sansom, T.R. Jeffry Evans, Colin J. McKay, Karin A. Oien   +9 more
openalex   +1 more source

Precision medicine strategy in pancreatic ductal adenocarcinoma. [PDF]

ESMO Open
Tarabay A, Swales L, Smolenschi C, Akoury E, Valéry M, Fuerea A, Pudlarz T, Boige V, Rouleau E, Gelli M, Bani MA, Barbe R, Hollebecque A, Ducreux M, Boilève A.   +14 more
europepmc   +1 more source

Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma

, 2020
Na Chang, Lingling Cui, Yahong Luo, Zhihui Chang, Bing Yu, Zhaoyu Liu   +5 more
openalex   +2 more sources

Supplementary Figure 1 from MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

, 2023
Nigel B. Jamieson, Douglas C. Morran, Jennifer P. Morton, Asif Ali, Euan J. Dickson, C. Ross Carter, Owen J. Sansom, T.R. Jeffry Evans, Colin J. McKay, Karin A. Oien   +9 more
openalex   +1 more source

BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma? [PDF]

Int J Mol Sci
Zekavat L, Jain A.
europepmc   +1 more source